Showing 6,901 - 6,920 results of 11,116 for search 'significantly ((((((teer decrease) OR (we decrease))) OR (mean decrease))) OR (observed decrease))', query time: 0.74s Refine Results
  1. 6901

    Structure of the OHC model. by Yihan Liao (13807348)

    Published 2025
    “…<p>In this study, we employed Depthwise Separable Convolution to significantly reduce the model's parameters, decreasing complexity, thus expediting training and reducing the risk of overfitting. …”
  2. 6902

    Table 2_Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study.xlsx by Margot Giocondo (21435500)

    Published 2025
    “…Additionally, a greater postoperative drop in PTH was associated with larger BMD gains at the spine (SD 0.07; mean 0.03) and left femur bone (SD 0.06; mean 0.02). …”
  3. 6903

    Data Sheet 4_Efficacy and safety of Shuxuening injection in intracerebral hemorrhage: a systematic review and meta-analysis.pdf by Wenting Song (822582)

    Published 2025
    “…Compared with the control group, the treatment group demonstrated better performance in reducing neurological impairment score [SMD = −0.99, 95% CI −1.24, −0.73], improving overall efficacy [RR = 1.22, 95% CI 1.14, 1.30] and ADL score [SMD = 2.01, 95%CI 1.55, 2.46], as well as decreasing the cerebral hematoma volume [MD = −6.98, 95% CI −8.76, −5.20] and cerebral edema volume [MD = −3.67, 95%CI -5.27, −2.06], with statistically significant differences observed. …”
  4. 6904

    Table 1_Factors influencing bone mineral density in hyperparathyroidism phenotypes: a prospective study.xlsx by Margot Giocondo (21435500)

    Published 2025
    “…Additionally, a greater postoperative drop in PTH was associated with larger BMD gains at the spine (SD 0.07; mean 0.03) and left femur bone (SD 0.06; mean 0.02). …”
  5. 6905

    Data Sheet 3_Efficacy and safety of Shuxuening injection in intracerebral hemorrhage: a systematic review and meta-analysis.pdf by Wenting Song (822582)

    Published 2025
    “…Compared with the control group, the treatment group demonstrated better performance in reducing neurological impairment score [SMD = −0.99, 95% CI −1.24, −0.73], improving overall efficacy [RR = 1.22, 95% CI 1.14, 1.30] and ADL score [SMD = 2.01, 95%CI 1.55, 2.46], as well as decreasing the cerebral hematoma volume [MD = −6.98, 95% CI −8.76, −5.20] and cerebral edema volume [MD = −3.67, 95%CI -5.27, −2.06], with statistically significant differences observed. …”
  6. 6906

    Data Sheet 2_Efficacy and safety of Shuxuening injection in intracerebral hemorrhage: a systematic review and meta-analysis.pdf by Wenting Song (822582)

    Published 2025
    “…Compared with the control group, the treatment group demonstrated better performance in reducing neurological impairment score [SMD = −0.99, 95% CI −1.24, −0.73], improving overall efficacy [RR = 1.22, 95% CI 1.14, 1.30] and ADL score [SMD = 2.01, 95%CI 1.55, 2.46], as well as decreasing the cerebral hematoma volume [MD = −6.98, 95% CI −8.76, −5.20] and cerebral edema volume [MD = −3.67, 95%CI -5.27, −2.06], with statistically significant differences observed. …”
  7. 6907

    Data Sheet 1_Efficacy and safety of Shuxuening injection in intracerebral hemorrhage: a systematic review and meta-analysis.pdf by Wenting Song (822582)

    Published 2025
    “…Compared with the control group, the treatment group demonstrated better performance in reducing neurological impairment score [SMD = −0.99, 95% CI −1.24, −0.73], improving overall efficacy [RR = 1.22, 95% CI 1.14, 1.30] and ADL score [SMD = 2.01, 95%CI 1.55, 2.46], as well as decreasing the cerebral hematoma volume [MD = −6.98, 95% CI −8.76, −5.20] and cerebral edema volume [MD = −3.67, 95%CI -5.27, −2.06], with statistically significant differences observed. …”
  8. 6908

    Video 2_Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.mp4 by Yizhe Song (11859734)

    Published 2025
    “…Concurrently, laboratory results revealed a decrease in key renal biomarkers (SCr, BUN, and P) and an amelioration of the non-regenerative anemia. …”
  9. 6909

    Sample size in each occupational subgroup. by Maryam Rafiee (10368504)

    Published 2025
    “…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …”
  10. 6910

    Correlation between different study variables. by Maryam Rafiee (10368504)

    Published 2025
    “…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …”
  11. 6911

    Study flow diagram. by Maryam Rafiee (10368504)

    Published 2025
    “…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …”
  12. 6912

    Video 1_Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.mp4 by Yizhe Song (11859734)

    Published 2025
    “…Concurrently, laboratory results revealed a decrease in key renal biomarkers (SCr, BUN, and P) and an amelioration of the non-regenerative anemia. …”
  13. 6913

    Final data used in the study. by Maryam Rafiee (10368504)

    Published 2025
    “…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …”
  14. 6914

    Video 3_Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.mp4 by Yizhe Song (11859734)

    Published 2025
    “…Concurrently, laboratory results revealed a decrease in key renal biomarkers (SCr, BUN, and P) and an amelioration of the non-regenerative anemia. …”
  15. 6915

    Data Sheet 1_Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.pdf by Yizhe Song (11859734)

    Published 2025
    “…Concurrently, laboratory results revealed a decrease in key renal biomarkers (SCr, BUN, and P) and an amelioration of the non-regenerative anemia. …”
  16. 6916

    Data Sheet 1_Innovative functional juice enriched with native probiotics for enhanced nutrition and antimicrobial properties.docx by Gabriela N. Tenea (10930824)

    Published 2025
    “…</p>Results<p>The results showed greater cell viability of Cys5-4 (8.84 ×10<sup>7</sup> CFU/ml), whereas a statistically significant (p < 0.05) decrease was registered for LP strain (1.90 × 10<sup>5</sup> CFU/mL) on the 15th day of storage with refrigeration. …”
  17. 6917

    Data Sheet 1_Development of an LC-MS/MS method for astaxanthin quantification in shrimp tissues and its application to detect astaxanthin variations during ovary development stages... by Shuo Diao (1967698)

    Published 2025
    “…During the ovarian developmental stages, astaxanthin was predominantly sequestered in the hepatopancreas during early phases, with concentrations ranging from 21.3 μg/g to 29.1 μg/g, representing a 43- to 59-fold increase compared to ovarian concentrations. However, a significant redistribution of astaxanthin was observed during the post-developmental stage, characterized by a substantial decrease to 5.74 μg/g in the hepatopancreas, concomitant with an increase to 7.47 μg/g in ovarian tissue.…”
  18. 6918

    Video 4_Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe feline chronic kidney disease.mp4 by Yizhe Song (11859734)

    Published 2025
    “…Concurrently, laboratory results revealed a decrease in key renal biomarkers (SCr, BUN, and P) and an amelioration of the non-regenerative anemia. …”
  19. 6919

    Data Sheet 1_Tobacco- and alcohol-attributable burden of early-onset lip, oral cavity, and pharyngeal cancer in 204 countries and territories from 1990 to 2019, with projections to... by Xingzhu Dai (11086206)

    Published 2024
    “…Background<p>Rising trends in early-onset Lip and oral cavity cancer (LOC) and Other pharyngeal cancer (OPC) burden had been observed. This study aimed to evaluate the burdens of LOC and OPC attributable to tobacco and alcohol in young adults aged 15-49 years from 1990 to 2040.…”
  20. 6920

    Demographic characteristics of participants. by Maryam Rafiee (10368504)

    Published 2025
    “…The highest prevalence of WMSDs (89.5%) was observed in the lower back region among women aged 45–54 years. …”